Market for Asthma Treatment is Extrapolated to reach US$ 35.4 billion by 2033-end: Fact.MR

 


 The global asthma treatment market is projected to expand at a steady CAGR of 2.3% over the assessment period of 2020-2027. The hospital pharmacies with huge drug inventories are likely to remain a vital distribution channel in the global market, as it becomes convenient for patients to buy drugs straightaway after diagnosis.

“Growing usage of online shopping channels providing same-day / next-day delivery attributes and striking deals will boost sales via online pharmacies. The inclination towards ordering medications via online pharmacies will gain more prominence towards 2027 end.” says the Fact.MR report.

Download Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=4422?AS

Asthma Treatment Market- Key Takeaways

  • The global asthma treatment market to reach a market valuation of US$ 10 Bn by 2027 end.
  • North America is projected to remain dominant in the market capturing the highest market share over the forecast period.
  • Long-term asthma control medications to gain traction in the global market as compared to quick-relief medications.
  • Inhaled route of administration segment has foreseen a significant uptick in the global market.
  • Sales through online pharmacies are expected to skyrocket in the approaching years.

Asthma Treatment Market – Driving Factors

  • Growing awareness regarding the asthmatic condition and its timely diagnosis is enhancing the demand prospects of the market.
  • Hospital pharmacies are anticipated to catalyze sales of asthma treatment over the forecast period.
  • Rising demand for better health facilities and innovation in biological drugs are projected to propel the market growth.

Prime asthma treatment companies are focusing on launching new treatment drugs to maximize their sales potential and gain a competitive advantage over other market players in the industry landscape.

  • In January 2023, Lupin, a multinational pharmaceutical company based in India announced the launch of a new drug combination to manage and treat asthma among patients. The new fixed-dose triple drug combination (FDC) of Indacaterol, Glycopyrronium, and Mometasone was launched under the brand name DIFIZMA in India.

Major Stakeholders

  • Boehringer Ingelheim International GmbH
  • Teva Pharmaceutical Industries Ltd.
  • AstraZeneca
  • Merck & Co. Inc.
  • Novartis AG
  • Sanofi
  • F. Hoffmann-La Roche Ltd.
  • Sumitomo Dainippon Pharma Co. Ltd.
  • Mylan N.V.
  • GlaxoSmithKline Plc

Asthma Treatment Market Size & Growth Forecast by Fact.MR

Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=4422?AS

Workflow Optimization

  • By Treatment :
    • Long-term Asthma Control Medications
      • Combination Inhalers
      • Inhaled Corticosteroids
      • Long-acting Beta Agonists
      • Leukotriene Modifiers
      • Theophylline
      • Others (Reslizumab, Benralizumab, etc.)
    • Quick-relief (Rescue) Medications
      • Short-acting Beta Agonists
      • Ipratropium (Atrovent)
      • Oral & Intravenous Corticosteroids
  • By Route of Administration :
    • Inhaled
    • Oral
    • Intravenous
    • Subcutaneous
  • By Distribution Channel :
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Region :
    • North America
    • Latin America
    • Europe
    • APAC
    • MEA

The report covers following Asthma treatment  insights and assessment that are helpful for all participants involved in the Asthma treatment :

  • Data on recently introduced regulations and their impact on key industries and on demand in Asthma treatment
  • Latest industry Asthma treatment  with key analysis of market drivers, trends, and influencing factors
  • Key trends Analysis of Asthma treatment  and changing consumer preferences in major industries.
  • Changing Asthma treatment  demand and consumption of diverse products
  • Major trends underlining funding by key investors in numerous countries
  • New investment opportunities in diverse technology and product or service types
  • Comprehensive data and Competitive analysis of Asthma treatment    major players
  • Asthma treatment  sales in US will grow at a steady pace, driven by growing consumer confidence and economic recovery

More on the Report

The Fact.MR’s market research report provides in-depth insights into the asthma treatment market. The market is scrutinized based on treatment type (long-term asthma control medications and quick-relief (rescue) medications), route of administration (inhaled, oral, intravenous, and subcutaneous), and distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies), across five major regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa (MEA)).

Check out more related studies published by Fact.MR Research:
https://www.globenewswire.com/news-release/2023/02/14/2607922/0/en/Global-Hernia-Mesh-Devices-Market-Is-Projected-To-Reach-US-6-99-Billion-by-the-End-of-2033-Fact-MR-Analysis.html

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Comments

Post a Comment

Popular posts from this blog

Caviar Market Ongoing Trends and Recent Developments

 The global caviar market is expected to reach a value of US$ 975 million by 2033-end, according to data provided by Fact.MR, a market research and competitive intelligence provider. Worldwide consumption of caviar is predicted to increase at a CAGR of 7.6% through 2033. Demand for caviar is driven by increasing health consciousness among people around the world. In addition, rising standards of living and increased production of caviar from aquaculture are also driving their sales. Docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) are the two pivotal omega-3 fatty acids that are abundant in this delicacy. These fatty acids are responsible for noticeable health advantages. Dietary Guidelines for Americans mentions that an individual needs to get around 250 mg of DHA and EPA each day. Download Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=8331 Report Attributes              Details Forecast Period          2022
Read more

Ferrous Sulfate Market Size to Reach US$ 3.3 Billion by 2033

  Global Ferrous sulphate market is projected to reach US$ 2.5 billion in 2023 and US$ 3.3 billion by the end of 2033, growing at a CAGR of 2.9%.Ferrous sulphate is an iron salt that is produced as a by-product of the sulphate process used to make titanium dioxide (TiO2). Numerous industries, including agriculture, construction, animal nutrition, etc., employ ferrous sulphate extensively. Fertilizers frequently contain ferrous sulphate, which gives plants the iron they require. Ferrous sulphate increases the mineral content of the diet because it is often used as a component in cattle and poultry feed. It also helps animals thrive and serves as a blood tonic for livestock. Download Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=1954?AS Key Players KRONOS Worldwide Inc. Crown Technology, Inc. Verdesian Life Sciences LLC Venator Materials PLC. Guangxi Jintao Titanium Co.Ltd. Chemland Group Key Points Covered in the Ferrous Sulfate Report: • The Ferr
Read more

Automotive Lighting Market 2023: Vendor Overview By Key Customers, Offerings, Geographic And Segment Focus With Forecast To 2032

Image
          Sales for automotive lighting are expected to surpass US$ 45 Bn by registering a positive CAGR of 6% through the forecast period 2021-2031. Increasing demand for LED lights along with halogen lights is propelling the demand for automotive lighting. Historically, from 2016 to 2020, the sales of automotive lighting exceeded the sales of US$ 20 Bn by the end of the aforementioned period. As the COVID-19 pandemic took hold, sales of vehicles observed a decline in the initial quarters, attributed to substantial shortfalls in automotive output amid mandatory lockdowns. However, since Q4 2020, restrictions have lifted. This, in turn, is expected to upsurge the sales of automotive lighting. For Critical Insights on This Market, Request a Sample Report https://www.factmr.com/connectus/sample?flag=S&rep_id=4795 Manufacturers of automotive lighting are focusing on improving the efficiency of lights. In addition, these lights consume lesser energy. Due to the factors mentioned above,
Read more